<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04483999</url>
  </required_header>
  <id_info>
    <org_study_id>VRSQ9</org_study_id>
    <nct_id>NCT04483999</nct_id>
  </id_info>
  <brief_title>Turkish Validity and Reliability Study of Virtual Reality Sickness Questionnaire</brief_title>
  <official_title>Turkish Validity and Reliability Study of Virtual Reality Sickness Questionnaire</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hacettepe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hacettepe University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is planned for the cultural adaptation and validity of the &quot;Virtual Reality
      Sickness Questionnaire&quot;.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Virtual reality (SG) creates a virtual environment that reflects a real environment and
      offers various experiences to users. Motion sickness can be observed in people after using
      virtual reality applications or simulation devices in education. There are questionnaires in
      the literature such as &quot;Simulator Sickness Questionnaire&quot; and &quot;Motion Sickness
      Questionnaire&quot;. However, these questionnaires are specific surveys to evaluate symptoms that
      develop after vehicle handling or use of simulation devices for pilot training, while they
      are not ideal questionnaires to evaluate symptoms that may develop after virtual reality
      applications. Because there are important differences between virtual reality systems and
      simulation systems in terms of the appearance of motion disturbance symptoms. For this
      reason, &quot;Virtual Reality Sickness Questionnaire&quot; has been developed that can evaluate these
      symptoms.

      There is no Turkish version of the &quot;Virtual Reality Sickness Questionnaire&quot; in the
      literature. For this reason, this study is planned for the cultural adaptation and validity
      of the &quot;Virtual Reality Sickness Questionnaire&quot;.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 30, 2020</start_date>
  <completion_date type="Anticipated">March 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Virtual Reality Sickness Questionnaire</measure>
    <time_frame>Change from Baseline sickness after 1 hour later.</time_frame>
    <description>This questionnaire assess virtual reality sickness.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>graybiel scale</measure>
    <time_frame>Change from Baseline sickness after 1 hour later.</time_frame>
    <description>This questionnaire assess virtual reality sickness.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>international physical activity questionnaire</measure>
    <time_frame>All of the participants will assess at baseline with this scale.</time_frame>
    <description>This questionnaire assess physical activity level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tampa kinesiophobia scale</measure>
    <time_frame>All of the participants will assess at baseline with this scale.</time_frame>
    <description>This questionnaire assess kinesiophobia.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Sickness Behavior</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy people
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Not having mental - cognitive problems,

          -  Being a volunteer

        Exclusion Criteria:

          -  Oculomotor and vestibular disease

          -  Cardiovascular, neurological and gastrointestinal problems
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>NEZİRE KOSE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>GÜL YAZICIOĞLU</last_name>
    <phone>+903123051577</phone>
    <email>fsener@hacettepe.edu.tr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hatice Çetin</name>
      <address>
        <city>Ankara</city>
        <state>Sıhhiye</state>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>HATİCE ÇETİN</last_name>
      <phone>03123051577</phone>
      <email>haticebitirim@hacettepe.edu.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/29477332/</url>
    <description>URL</description>
  </link>
  <reference>
    <citation>Kim HK, Park J, Choi Y, Choe M. Virtual reality sickness questionnaire (VRSQ): Motion sickness measurement index in a virtual reality environment. Appl Ergon. 2018 May;69:66-73. doi: 10.1016/j.apergo.2017.12.016. Epub 2018 Jan 16.</citation>
    <PMID>29477332</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 20, 2020</study_first_submitted>
  <study_first_submitted_qc>July 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2020</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hacettepe University</investigator_affiliation>
    <investigator_full_name>HATİCE ÇETİN</investigator_full_name>
    <investigator_title>Research Assisstant</investigator_title>
  </responsible_party>
  <keyword>virtual reality</keyword>
  <keyword>sickness</keyword>
  <keyword>validity</keyword>
  <keyword>reliability</keyword>
  <keyword>turkish</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Illness Behavior</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

